Dr. Agarwal's Health Care Limited (AGARWALEYE) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Dr. Agarwal's Health Care Limited stock ₹92.41, price ₹551, that is 83.2% below the price, quality 41 out of 100. Rating: strongly overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Dr. Agarwal's Health Care Limited
AGARWALEYE · NSEFar too expensive (fair value 83% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
21‑month range ₹334.05 – ₹560.70 · fair‑value band ₹55.74 – ₹115.51 · the ₹550.80 price screens above the ₹92.41 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Dr. Agarwal's Health Care is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally.
Show moreShow less
It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens.
The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services.
It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.
Stock analysis
Dr. Agarwal's Health Care Limited (AGARWALEYE) currently trades at ₹550.80, while our model-based Fair Value estimate is ₹92.41, 83% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹155.78 per share, and 0 of the 25 models we run sit above the ₹550.80 price.
Bear case: the Asset-Based group reads lowest at ₹18.44, and 25 of the 25 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹55.74 (bear) to ₹115.51 (bull), the price of ₹550.80 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Dr. Agarwal's Health Care Limited reported revenue of ₹20.8B in FY2026 versus ₹7.0B in FY2022, a compound +31.5%/yr. Reported net income was ₹1.3B in FY2026, compounding +37.1%/yr from FY2022.
Key figures
Market cap ₹176B (≈ $1.9B) Small · P/E ratio 103.5 · P/S ratio 9.38 · EPS (TTM) ₹5.32 · Net margin 7.2% · Return on equity 9.7% · Return on assets (EBIT) 12.4% (5-year average) · Operating margin 14.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 35% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −43% fair-value upside, at −83%, AGARWALEYE screens richer than that median.
Fair Value models
All 25 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Compare Dr. Agarwal's Health Care Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $89.08 | $131.27 | +47% | vs AGARWALEYE |
| EssilorLuxottica Société anonyme EL | €182.35 | €196.22 | +8% | vs AGARWALEYE |
| Intuitive Surgical, Inc ISRG | $443.59 | $353.90 | −20% | vs AGARWALEYE |
| Medline Inc MDLN | $39.47 | $28.59 | −28% | vs AGARWALEYE |
| Alcon Inc ALC | CHF 61.36 | CHF 34.91 | −43% | vs AGARWALEYE |
| Becton, Dickinson and Company BDX | $218.03 | $97.80 | −55% | vs AGARWALEYE |
| Straumann Holding STMN | CHF 107.20 | CHF 45.50 | −58% | vs AGARWALEYE |
| West Pharmaceutical Services, Inc WST | $416.42 | $139.22 | −67% | vs AGARWALEYE |
| Sartorius Stedim Biotech S.A DIM | €223.20 | €54.82 | −75% | vs AGARWALEYE |
| Sartorius Aktiengesellschaft SRT | €225.50 | €46.44 | −79% | vs AGARWALEYE |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Dr. Agarwal's Health Care Limited (AGARWALEYE) overvalued or undervalued?
What is the fair value of AGARWALEYE?
What is the quality score of AGARWALEYE?
What is the price target for Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the Dr. Agarwal's Health Care Limited stock forecast for 2026?
What is the revenue of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What growth is priced into Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What discount rate (WACC) does the fair value of AGARWALEYE use?
What is a reverse DCF?
How much growth has Dr. Agarwal's Health Care Limited (AGARWALEYE) delivered so far?
How fast is the sector of Dr. Agarwal's Health Care Limited (AGARWALEYE) growing?
What is the free cash flow yield of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the intrinsic value of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
Is Dr. Agarwal's Health Care Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of AGARWALEYE?
How much is Dr. Agarwal's Health Care Limited worth?
What do the bullish and bearish scenarios say about AGARWALEYE?
What is the P/E ratio of AGARWALEYE?
How solid is the balance sheet of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
How far is AGARWALEYE from its 52-week high?
Which stocks are comparable to Dr. Agarwal's Health Care Limited?
Is Dr. Agarwal's Health Care Limited stock attractive at the current price?
How is the fair value of AGARWALEYE calculated?
Is it still worth investing in stocks now?
What is the share price of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What should I pay attention to with Dr. Agarwal's Health Care Limited right now?
Key figures of Dr. Agarwal's Health Care Limited
How large is the market capitalisation of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the P/S ratio of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What are the earnings per share of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the net margin of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the return on equity of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the EBIT return on assets of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
What is the operating margin of Dr. Agarwal's Health Care Limited (AGARWALEYE)?
How fast is revenue growing at Dr. Agarwal's Health Care Limited (AGARWALEYE)?
How fast are earnings growing at Dr. Agarwal's Health Care Limited (AGARWALEYE)?
How much net debt does Dr. Agarwal's Health Care Limited (AGARWALEYE) carry?
Watch Dr. Agarwal's Health Care Limited in the live analysis
One click puts Dr. Agarwal's Health Care Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.